Transparency rules a tangle at cancer journals
Fri,22 Jul 2011 02:52 PM PDT Reuters - NEW YORK (Reuters Health) - Economic ties that could bias drug trials and patient care might remain hidden due to tangled disclosure rules at medical journals, a new study reveals. Full Story |
Take-home chlamydia tests tied to more screening
Fri,22 Jul 2011 02:02 PM PDT Reuters - NEW YORK (Reuters Health) - Women at risk for chlamydia infections are more likely to get tested if they can do it at home instead of going to a clinic, suggests new research. Full Story |
Parents' stress tied to pollution's effect on kids
Fri,22 Jul 2011 01:11 PM PDT Reuters - NEW YORK (Reuters Health) - Children living in high-stress households are more vulnerable to lung damage from traffic pollution than children whose parents are less stressed out, according to the results of a new study. Full Story |
Japanese herb for hot flashes fails in U.S. trial
Fri,22 Jul 2011 11:51 AM PDT Reuters - NEW YORK (Reuters Health) - An herbal remedy widely used in Japan to ease menopause symptoms failed to show the same benefits in a clinical trial of U.S. women, researchers report. Full Story |
Childhood pets linked to lower allergy risk
Fri,22 Jul 2011 10:38 AM PDT Reuters - NEW YORK (Reuters Health) - Good news for families that would love to have a furry dog or cat but hesitate for fear the kids might become allergic: Fido or Kitty might actually be good for children's health, scientists say. Full Story |
Childhood pets linked to lower allergy risk
Fri,22 Jul 2011 10:37 AM PDT Reuters - NEW YORK (Reuters Health) - Good news for families that would love to have a furry dog or cat but hesitate for fear the kids might become allergic: Fido or Kitty might actually be good for children's health, scientists say. Full Story |
Life expectancy rises with AIDS therapy in Uganda
Fri,22 Jul 2011 07:24 AM PDT Reuters - NEW YORK (Reuters Health) - Ugandan HIV and AIDS patients receiving antiretroviral "cocktail" therapy can expect to live nearly as long as their compatriots who don't have HIV, a new study finds. Full Story |
Under-eye fat transfer lasts a few years: study
Fri,22 Jul 2011 07:22 AM PDT Reuters - NEW YORK (Reuters Health) - Fat transferred under the eyes to create a younger-looking face can last for at least three years, suggests a new study of people who had the surgery. Full Story |
Health at birth linked to teen academic performance
Fri,22 Jul 2011 07:20 AM PDT Reuters - NEW YORK (Reuters Health) - Babies who get low scores on a test of heart, lung and brain function given just a few minutes after birth may be more likely to need special education as teenagers, suggests a new study from Sweden. Full Story |
 NEW YORK (Reuters Health) - After a heart attack, quitting smoking may offer a patient more benefits than any medication, but Italian researchers say the flipside is that resuming smoking after leaving the hospital can raise the same patient's risk of dying as much as five-fold. |
J&J warns doctors of Doxil cancer-drug shortage
Thu,21 Jul 2011 02:06 PM PDT Reuters - NEW YORK (Reuters) - Johnson & Johnson has cautioned doctors not to begin treatment with its Doxil cancer drug because of shortages of the medicine made by an outside manufacturer. Full Story |
Edwards Lifesciences profit edges higher
Thu,21 Jul 2011 01:15 PM PDT Reuters - CHICAGO (Reuters) - Edwards Lifesciences Corp on Thursday reported slightly higher second-quarter profit, led by increased sales of transcatheter heart valves in Europe.Full Story |
Edwards Lifesciences profit edges higher
Thu,21 Jul 2011 01:14 PM PDT Reuters - CHICAGO (Reuters) - Edwards Lifesciences Corp on Thursday reported slightly higher second-quarter profit, led by increased sales of transcatheter heart valves in Europe.Full Story |
 NEW YORK (Reuters Health) - Reservists returning from Iraq orAfghanistan may have more trouble adjusting to life at home than full-time soldiers do -- and that can take a toll on their mental well-being, a UK study finds. |
Benefit of MS drugs comes at steep price: study
Thu,21 Jul 2011 12:16 PM PDT Reuters - NEW YORK (Reuters Health) - Drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost, according to a study out Wednesday. Full Story |
No comments:
Post a Comment
No adult content please.
Articles accepted having references.
No advertisement accepted.